iThera Medical
- Company typePrivate
- Founded2010
- HeadquartersMünchen, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
iThera Medical firmographics
Firmographics- Name
- iThera Medical
- Legal name
- iThera Medical GmbH
- Website
- https://ithera-medical.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
iThera Medical industry classification
Industry- Product category
- Medical Imaging Equipment
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Analytical Laboratory Instrument Manufacturing (334516), Scientific Research and Development Services (5417)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Mammography & Breast Imaging Systems (HLAHABAF)
- akta.pro secondary industries
- Ultrasound & Echography Systems (HLAHABAD), Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE)
Keywords
Where iThera Medical is headquartered
LocationHeadquarters
- HQ city
- München
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
iThera Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Medical Device Sales (Planned): iThera Medical plans to commercialize clinical MSOT devices for diagnostic imaging. The company is developing a clinical MSOT device and seeking regulatory approvals in Europe and the US, indicating a future hardware/device revenue model.
Distribution channels1 record
Marketing channels3 records
iThera Medical product offering
Product offeringCore offering
iThera Medical develops proprietary Multispectral Optoacoustic Tomography (MSOT) technology that combines optical excitation with ultrasound detection to deliver non-invasive, high-resolution diagnostic imaging. The company is translating its MSOT platform from research into clinical applications for detecting disease biomarkers related to inflammation, fibrosis, and cancer, and is developing a clinical MSOT device targeting regulatory approvals in Europe and the United States.
Product overview
iThera Medical is a Munich-based medical device company that develops Multispectral Optoacoustic Tomography (MSOT) technology for clinical diagnostics. The company focuses on optoacoustic imaging systems designed to detect disease biomarkers related to inflammation, fibrosis, and cancer. Their technology translates MSOT from research settings into routine clinical use, with plans to develop clinical MSOT devices and obtain regulatory approvals in Europe and the US.
Differentiator
Problem solved
Functional benefit
Products and services
- MSOT (Multispectral Optoacoustic Tomography) Technology Proprietary optoacoustic imaging technology that enables non-invasive visualization and quantification of functional, chemical and morphological tissue parameters by detecting disease biomarkers related to inflammation, fibrosis, and cancer through light absorption and ultrasound detection.
- Clinical MSOT Device (in development) A clinical-grade MSOT imaging device intended for hospital and clinical use, designed to detect tumor vascularization through hemoglobin concentration measurements and translate optoacoustic imaging into routine clinical diagnostics.
Quantifiable outcome
- Non-invasive, radiation-free diagnostic imaging alternative to traditional mammography
Companies that use iThera Medical
Customer profileSegments1 record
Ideal customer profiles1 record
iThera Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
iThera Medical partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights4 records
iThera Medical competitors and assessment
Company assessmentDirect peers
- Seno Medical Instruments: Seno Medical develops the Imagio optoacoustic breast imaging system, the most direct US-based competitor to iThera's MSOT breast imaging application. Both target radiation-free, functional imaging of breast tumors using optoacoustic/photoacoustic principles.
- FUJIFILM VisualSonics: VisualSonics (owned by FUJIFILM) offers Vevo preclinical photoacoustic and high-frequency ultrasound imaging systems. It is the leading commercial supplier of optoacoustic imaging to the preclinical research market that iThera also serves with its MSOT technology.
- ENDRA Life Sciences: ENDRA develops the TAEUS thermoacoustic/photoacoustic platform for tissue characterization, including fatty liver disease and other clinical applications. It overlaps directly with iThera on photoacoustic imaging modality and clinical translation strategy.
- TomoWave Laboratories: TomoWave develops preclinical and research-grade optoacoustic/photoacoustic imaging systems, including the LOIS-3D small-animal imager. It is one of the closest technical peers to iThera in the multispectral optoacoustic tomography category.
Emerging players
- PhotoSound Technologies: PhotoSound Technologies supplies optoacoustic imaging subsystems, probes, and components used in preclinical and clinical research. It overlaps with iThera as a supplier/adjacent technology provider in the optoacoustic ecosystem.
Broad incumbents
- Hologic: Hologic is the dominant supplier of mammography and breast biopsy systems (e.g., 3Dimensions, Genius AI). As the incumbent in breast imaging, it is the most relevant established competitor iThera's MSOT breast application must displace or complement.
- Siemens Healthineers: Siemens Healthineers offers a broad portfolio of imaging modalities (MRI, CT, ultrasound, mammography) with global sales, clinical evidence, and reimbursement infrastructure. It is the type of incumbent iThera would compete with or partner alongside in the clinical imaging market.
- GE HealthCare: GE HealthCare is a global leader in diagnostic imaging including mammography, ultrasound, and molecular imaging. It represents both a potential competitor and a strategic channel partner for clinical optoacoustic imaging adoption.
- Canon Medical Systems: Canon Medical Systems offers a full suite of diagnostic imaging equipment including ultrasound, CT, MRI and mammography. Its breadth and installed-base reach are comparable to other large incumbents that could integrate or compete with optoacoustic imaging.
- Philips Healthcare: Philips Healthcare provides diagnostic imaging, ultrasound, and image-guided therapy solutions globally. Like other broad incumbents, it sets the competitive benchmark iThera's MSOT must meet on workflow integration, evidence, and reimbursement.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat2 records
Key risks2 records
Key highlights6 records
Customer concentration
iThera Medical social profiles
Digital presenceiThera Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
iThera Medical leadership team
Management profileNumber of profiles
Profiles2 records
iThera Medical funding detail
Funding detailFunding overview
Funding rounds8 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
iThera Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about iThera Medical
What does iThera Medical do?
iThera Medical develops proprietary Multispectral Optoacoustic Tomography (MSOT) technology that combines optical excitation with ultrasound detection to deliver non-invasive, high-resolution diagnostic imaging. The company is translating its MSOT platform from research into clinical applications for detecting disease biomarkers related to inflammation, fibrosis, and cancer, and is developing a clinical MSOT device targeting regulatory approvals in Europe and the United States.
Is iThera Medical a public or private company?
iThera Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was iThera Medical founded?
iThera Medical was founded in 2010. It employs 11 to 50 people.
Where is iThera Medical based?
iThera Medical is headquartered in München, Germany, in the Europe region.
How does iThera Medical make money?
One revenue line is on record: medical Device Sales (Planned).
Who are iThera Medical's main competitors?
Direct peers on record are Seno Medical Instruments, FUJIFILM VisualSonics, ENDRA Life Sciences and TomoWave Laboratories. PhotoSound Technologies is listed as an emerging player. Broad incumbents are Hologic, Siemens Healthineers, GE HealthCare, Canon Medical Systems and Philips Healthcare.
Does iThera Medical have an API?
No public API is recorded for iThera Medical.
What industry is iThera Medical in?
iThera Medical's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAHABAF, Mammography & Breast Imaging Systems, with a secondary code of HLAHABAD, Ultrasound & Echography Systems. Its NAICS code is 334510 and its SIC code is 3841.